Adaptor protein complex 4 deficiency: a paradigm of childhood-onset hereditary spastic paraplegia caused by defective protein trafficking.


Journal

Human molecular genetics
ISSN: 1460-2083
Titre abrégé: Hum Mol Genet
Pays: England
ID NLM: 9208958

Informations de publication

Date de publication:
15 01 2020
Historique:
received: 19 07 2019
revised: 22 10 2019
accepted: 05 12 2019
pubmed: 10 1 2020
medline: 21 10 2020
entrez: 10 1 2020
Statut: ppublish

Résumé

Deficiency of the adaptor protein complex 4 (AP-4) leads to childhood-onset hereditary spastic paraplegia (AP-4-HSP): SPG47 (AP4B1), SPG50 (AP4M1), SPG51 (AP4E1) and SPG52 (AP4S1). This study aims to evaluate the impact of loss-of-function variants in AP-4 subunits on intracellular protein trafficking using patient-derived cells. We investigated 15 patient-derived fibroblast lines and generated six lines of induced pluripotent stem cell (iPSC)-derived neurons covering a wide range of AP-4 variants. All patient-derived fibroblasts showed reduced levels of the AP4E1 subunit, a surrogate for levels of the AP-4 complex. The autophagy protein ATG9A accumulated in the trans-Golgi network and was depleted from peripheral compartments. Western blot analysis demonstrated a 3-5-fold increase in ATG9A expression in patient lines. ATG9A was redistributed upon re-expression of AP4B1 arguing that mistrafficking of ATG9A is AP-4-dependent. Examining the downstream effects of ATG9A mislocalization, we found that autophagic flux was intact in patient-derived fibroblasts both under nutrient-rich conditions and when autophagy is stimulated. Mitochondrial metabolism and intracellular iron content remained unchanged. In iPSC-derived cortical neurons from patients with AP4B1-associated SPG47, AP-4 subunit levels were reduced while ATG9A accumulated in the trans-Golgi network. Levels of the autophagy marker LC3-II were reduced, suggesting a neuron-specific alteration in autophagosome turnover. Neurite outgrowth and branching were reduced in AP-4-HSP neurons pointing to a role of AP-4-mediated protein trafficking in neuronal development. Collectively, our results establish ATG9A mislocalization as a key marker of AP-4 deficiency in patient-derived cells, including the first human neuron model of AP-4-HSP, which will aid diagnostic and therapeutic studies.

Identifiants

pubmed: 31915823
pii: 5698234
doi: 10.1093/hmg/ddz310
pmc: PMC7001721
doi:

Substances chimiques

AP4B1 protein, human 0
Adaptor Protein Complex 4 0
Adaptor Protein Complex beta Subunits 0
ATG9A protein, human 0
Autophagy-Related Proteins 0
MAP1LC3B protein, human 0
Membrane Proteins 0
Microtubule-Associated Proteins 0
Vesicular Transport Proteins 0
Iron E1UOL152H7

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

320-334

Subventions

Organisme : NICHD NIH HHS
ID : U54 HD090255
Pays : United States
Organisme : Medical Research Council
ID : G0802760
Pays : United Kingdom
Organisme : Medical Research Council
ID : G1001253
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 086598
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom
Organisme : Medical Research Council
ID : G108/638
Pays : United Kingdom
Organisme : The Dunhill Medical Trust
ID : R605/0717
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S01165X/1
Pays : United Kingdom

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Références

J Neurosci. 2016 Jun 1;36(22):5933-45
pubmed: 27251616
Neuron. 2018 Nov 21;100(4):783-797
pubmed: 30465765
Neuron. 2013 Jun 5;78(5):785-98
pubmed: 23764284
Cell Res. 2017 Feb;27(2):184-201
pubmed: 27934868
Autophagy. 2016;12(1):1-222
pubmed: 26799652
Ann Neurol. 2016 May;79(5):826-840
pubmed: 26971897
J Cell Biol. 2000 Feb 7;148(3):465-80
pubmed: 10662773
J Cell Biol. 2010 Sep 20;190(6):1005-22
pubmed: 20855505
Nat Genet. 2014 Mar;46(3):310-5
pubmed: 24487276
Genome Biol. 2006;7(10):R100
pubmed: 17076895
J Cell Sci. 2006 Sep 15;119(Pt 18):3888-900
pubmed: 16940348
Cell Rep. 2016 Oct 18;17(4):1053-1070
pubmed: 27760312
Mol Biol Cell. 2012 May;23(10):1860-73
pubmed: 22456507
Traffic. 2013 Feb;14(2):153-64
pubmed: 23167973
J Neurosci. 2011 Oct 12;31(41):14508-20
pubmed: 21994367
Nat Commun. 2018 Sep 27;9(1):3958
pubmed: 30262884
Hum Mol Genet. 2014 Sep 15;23(18):4859-74
pubmed: 24794856
Stem Cells. 2014 Feb;32(2):414-23
pubmed: 24123785
Stem Cell Res. 2019 Oct;40:101575
pubmed: 31525725
Mol Biol Cell. 1999 Aug;10(8):2787-802
pubmed: 10436028
Autophagy. 2020 Mar;16(3):391-407
pubmed: 31142229
Autophagy. 2014 Mar;10(3):431-41
pubmed: 24394643
Handb Clin Neurol. 2018;148:633-652
pubmed: 29478605
Traffic. 2017 Mar;18(3):159-175
pubmed: 28000370
Mol Cell. 2014 Feb 6;53(3):471-83
pubmed: 24440502
Nat Commun. 2016 Aug 11;7:12420
pubmed: 27510922
Brain. 2016 Feb;139(Pt 2):317-37
pubmed: 26715604
Hum Mol Genet. 2016 Aug 15;25(16):3588-3599
pubmed: 27378690
Hum Mol Genet. 2018 Jul 15;27(14):2517-2530
pubmed: 29726929
Am J Hum Genet. 2009 Jul;85(1):40-52
pubmed: 19559397
Am J Med Genet A. 2018 Feb;176(2):311-318
pubmed: 29193663
Nat Cell Biol. 2014 Nov;16(11):1069-79
pubmed: 25327288
PLoS Genet. 2018 Apr 26;14(4):e1007363
pubmed: 29698489
Brain. 2011 Feb;134(Pt 2):506-17
pubmed: 21228060
J Inherit Metab Dis. 2020 Jan;43(1):51-62
pubmed: 30854657
Autophagy. 2007 Nov-Dec;3(6):542-5
pubmed: 17611390
Cell Rep. 2017 Sep 5;20(10):2341-2356
pubmed: 28877469
J Med Genet. 2011 Feb;48(2):141-4
pubmed: 20972249
Am J Hum Genet. 2011 Jun 10;88(6):788-795
pubmed: 21620353
Neurol Genet. 2018 Jan 24;4(1):e217
pubmed: 29473051
Hum Mol Genet. 2014 Nov 1;23(21):5638-48
pubmed: 24908668
Proc Natl Acad Sci U S A. 2017 Dec 12;114(50):E10697-E10706
pubmed: 29180427
Brain. 2013 Jun;136(Pt 6):1708-17
pubmed: 23687123
J Histochem Cytochem. 2010 May;58(5):443-53
pubmed: 20124090
J Biol Chem. 2001 Apr 20;276(16):13145-52
pubmed: 11139587
J Cell Biol. 2012 Jul 23;198(2):219-33
pubmed: 22826123
Mov Disord. 2017 May;32(5):797-799
pubmed: 28150420
Dev Cell. 2010 Mar 16;18(3):425-36
pubmed: 20230749
Dev Cell. 2016 Jul 25;38(2):171-85
pubmed: 27396362
Brain. 2018 Oct 1;141(10):3052-3064
pubmed: 30169597
Autophagy. 2018;14(5):764-777
pubmed: 28513333
J Biol Chem. 1999 Mar 12;274(11):7278-85
pubmed: 10066790
J Cell Biol. 2012 Apr 2;197(1):141-60
pubmed: 22472443

Auteurs

Robert Behne (R)

Department of Neurology, The F.M. Kirby Neurobiology Center, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Department of Neurology, University Hospital Würzburg, 97080 Würzburg, Germany.

Julian Teinert (J)

Department of Neurology, The F.M. Kirby Neurobiology Center, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Division of Pediatric Neurology and Metabolic Medicine, Center for Child and Adolescent Medicine, University Hospital Heidelberg, 69120 Heidelberg, Germany.

Miriam Wimmer (M)

Department of Neurology, The F.M. Kirby Neurobiology Center, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.

Angelica D'Amore (A)

Department of Neurology, The F.M. Kirby Neurobiology Center, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Molecular Medicine, IRCCS Fondazione Stella Maris, 56018 Pisa, Italy.

Alexandra K Davies (AK)

Cambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 0XY, UK.
Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, 82152 Martinsried, Germany.

Joseph M Scarrott (JM)

Department of Neuroscience, Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield S10 2HQ, UK.

Kathrin Eberhardt (K)

Department of Neurology, The F.M. Kirby Neurobiology Center, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.

Barbara Brechmann (B)

Department of Neurology, The F.M. Kirby Neurobiology Center, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.

Ivy Pin-Fang Chen (IP)

Translational Neuroscience Center, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.

Elizabeth D Buttermore (ED)

Translational Neuroscience Center, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.

Lee Barrett (L)

Translational Neuroscience Center, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.

Sean Dwyer (S)

Translational Neuroscience Center, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.

Teresa Chen (T)

Translational Neuroscience Center, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.

Jennifer Hirst (J)

Cambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 0XY, UK.

Antje Wiesener (A)

Institute of Human Genetics, Friedrich-Alexander Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.

Devorah Segal (D)

Division of Pediatric Neurology, Department of Pediatrics, Weill Cornell Medicine, New York City, NY 10021, USA.

Andrea Martinuzzi (A)

Scientific Institute, IRCCS E. Medea, Unità Operativa Conegliano, 31015 Treviso, Italy.

Sofia T Duarte (ST)

Department of Pediatric Neurology, Centro Hospitalar de Lisboa Central, 1169-050 Lisbon, Portugal.

James T Bennett (JT)

Division of Genetic Medicine, Department of Pediatrics, University of Washington, Seattle, WA 98195, USA.

Thomas Bourinaris (T)

Department of Molecular Neuroscience, UCL Institute of Neurology, London WC1E 6BT, UK.

Henry Houlden (H)

Department of Molecular Neuroscience, UCL Institute of Neurology, London WC1E 6BT, UK.

Agathe Roubertie (A)

Pediatric Neurology, CHU Montpellier, 34295 Montpellier, France.

Filippo M Santorelli (FM)

Molecular Medicine, IRCCS Fondazione Stella Maris, 56018 Pisa, Italy.

Margaret Robinson (M)

Cambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 0XY, UK.

Mimoun Azzouz (M)

Department of Neuroscience, Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield S10 2HQ, UK.

Jonathan O Lipton (JO)

Department of Neurology, The F.M. Kirby Neurobiology Center, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Division of Sleep Medicine, Harvard Medical School, Boston, MA 02115, USA.

Georg H H Borner (GHH)

Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, 82152 Martinsried, Germany.

Mustafa Sahin (M)

Department of Neurology, The F.M. Kirby Neurobiology Center, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Translational Neuroscience Center, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.

Darius Ebrahimi-Fakhari (D)

Department of Neurology, The F.M. Kirby Neurobiology Center, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH